Duchenne muscular dystrophy (DMD) devastates young lives. This progressive disease, stemming…
Category: Oligonucleotides
Home /
What are they? Lipid nanoparticles (LNPs) are a crucial component in…
What is it? mRNA delivery by viral vectors is a promising…
What is it? It is unavoidable for patients to have no…
What is it? An anti-drug antibody, ADA, is an antibody that…
Therapeutic oligonucleotides are important for altering targeted RNA pathways through a…
As scientists, doctors and researchers race to develop vaccines and therapeutics…
Introduction Researchers are developing novel, safer treatments for cancer, but bringing new oncology therapies to market is challenging. This white paper will examine the…
Introduction As global obesity rates continue to rise, the search for effective treatments is more critical than ever. Obesity is associated with an increased…
Introduction Changes in how clinical trials are managed in the European Union (EU), mandated by the European Union Clinical Trial Regulation 536/2014 (EU CTR),…
QPS Selects Ryght AI as an Exclusive AI Partner for Clinical Trial Optimization and Automation while adding to Ryght’s global site network. Laguna Beach,…
NEWARK, Delaware, November 13, 2024/BUSINESS WIRE/ — QPS Holdings, LLC announced today that their Springfield campus, QPS Missouri, has launched a new Cell Therapy…
NEWARK, Delaware, June 26, 2024/BUSINESS WIRE/ — QPS Holdings, LLC (QPS), a leading global contract research organization (CRO), is pleased to announce new laboratory…
Webinars
Promising Clinical Trial Results Suggest a Path Forward in Treating DMD
November 18, 2024
Duchenne muscular dystrophy (DMD) devastates young lives. This progressive disease, stemming from mutations in the gene that encodes the protein dystrophin, weakens muscles and strips
Messenger RNA Delivery by Lipid Nanoparticles (LNPs)
November 1, 2023
What are they? Lipid nanoparticles (LNPs) are a crucial component in the delivery of RNA drugs, including mRNA-based therapeutics and small interfering RNA (siRNA) molecules.
mRNA Delivery by Viral Vectors
October 25, 2023
What is it? mRNA delivery by viral vectors is a promising approach in the field of gene therapy and vaccine development. Viral vectors are modified
Oligonucleotide Therapeutics: Drug-Drug Interactions (DDI)
October 11, 2023
What is it? It is unavoidable for patients to have no other substances in their body when being administered a treatment. Whether it is a
Oligonucleotide Anti-Drug Antibodies (ADAs)
September 22, 2023
What is it? An anti-drug antibody, ADA, is an antibody that binds to the therapeutic drug. They are formed as an immune response when a
Understanding Therapeutic Oligonucleotides ADME
August 23, 2023
Therapeutic oligonucleotides are important for altering targeted RNA pathways through a variety of mechanisms, making them a versatile tool in drug development. Understanding their ADME
Oligonucleotides: Innovations in Antivirals for Novel Viruses
November 2, 2020
As scientists, doctors and researchers race to develop vaccines and therapeutics for SARS-CoV-2, several drugs have emerged as promising candidates. Oligonucleotide therapeutics are one such
Introduction Researchers are developing novel, safer treatments for cancer, but bringing new oncology therapies to market is challenging. This white paper will examine the…
Introduction As global obesity rates continue to rise, the search for effective treatments is more critical than ever. Obesity is associated with an increased…
Introduction Changes in how clinical trials are managed in the European Union (EU), mandated by the European Union Clinical Trial Regulation 536/2014 (EU CTR),…
QPS Selects Ryght AI as an Exclusive AI Partner for Clinical Trial Optimization and Automation while adding to Ryght’s global site network. Laguna Beach,…
NEWARK, Delaware, November 13, 2024/BUSINESS WIRE/ — QPS Holdings, LLC announced today that their Springfield campus, QPS Missouri, has launched a new Cell Therapy…
NEWARK, Delaware, June 26, 2024/BUSINESS WIRE/ — QPS Holdings, LLC (QPS), a leading global contract research organization (CRO), is pleased to announce new laboratory…
